Printer Friendly
The Free Library
14,558,366 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

sanofi-aventis Japan to Merge Sanofi-Synthelabo and Aventis Pharma Japan in January.


Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Nov 2, 2005 - (JCNN JCNN Japan Corporate News Network ) - sanoif-aventis Japan announced on October October: see month.  31 that the legal merger of Sanofi-Synthelabo and Aventis Pharma Japan was officially approved by the two companies.

Accordingly, the new company, sanofi-aventis K.K., will be formally inaugurated as of January 1, 2006. With this move, the sanofi-aventis Group will go on offensive in Japan, the world's second largest pharmaceutical market.

Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Nov 2, 2005
Words:79
Previous Article:Citizen to Release New User-friendly Digital Thermometer.
Next Article:Merck KGaA Unveils Its Japan Business Reorganization Plan.



Related Articles
Aventis Pharma Obtains Additional Approval for Taxoid Antitumor Agent TAXOTERE Injection.
Eisai to Distribute Actonel Osteoporosis Treatment for Ajinomoto.
Sanofi-aventis Japan Acquires Production and Sales Rights of Ancaron Antiarrhythmic Agent from Taisho Pharmaceutical.
Drug giant picks NJ for 670,000 s/f HQ.
Astellas Pharma, Sanofi-aventis Japan to Co-promtoe Myslee Tablet, Hypnotic Drug.
SANOFI-AVENTIS/REGENERON EXPAND VEGF TRAP PACT TO JAPAN.
Hillier Architecture: Ivan Rosa.(WHO'S NEWS in CONSTRUCTION & DESIGN)
Sanofi-aventis Acquires Production and Sales Rights to Antiplatelet Agent Plavix from Daiichi Pharmaceutical.
REIT buys 300,000 s/f NJ complex.
Taiho Pharmaceutical, Sanofi-aventis Conclude Licensing Agreement for Oral Pyrimidine Fluoride-derived Anticancer Agent TS-1.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles